The New York Stock Exchange ended the session with Pfizer rising 2.9% to $38.31 on Monday, following yesterday's upward trend. The New York Stock Exchange fell 1.35% to $14,006.10, following yesterday's upward trend on what was an all-around negative trend exchanging session today.
Pfizer today's close was $38.31, 3.99% below its 52-week high of $39.84.
Pfizer's sales growth is a negative 9.7% for the current quarter and a decline by 9.1% for the next. The company's growth estimates for the present quarter and the next is a negative 12.7% and a negative 12.5%, respectively.
Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.
Pfizer's stock is valued at $38.31 at 16:50 EST, below its 52-week high of $39.84 and way above its 52-week low of $26.45.
Pfizer's worth is above its 50-day moving average of $35.58 and way higher than its 200-day moving average of $34.80.According to Bloomberg Quint on Fri Nov 27, "Malaysia Inks Pact With Pfizer to Vaccinate 6.4 Million Citizens."
Stocks making the biggest moves in the premarket: astrazeneca, disney, Pfizer, Amazon & more. According to CNBC on Fri Nov 27, "The stocks making the biggest moves in premarket trading include AstraZeneca, Disney, Pfizer, Amazon, and more.."
According to Bloomberg Quint on Sat Nov 28, "U.K"
According to Bloomberg Quint on Sat Nov 28, "U.K"